Soft exosuit maker Hurotics raises 25 billion won Series A

Story summary

Soft exosuit maker Hurotics raised a 25 billion won Series A led by Atinum Investment, bringing its total funding to more than 33.5 billion won. New investors include strategic investors Daewoong, Naver and Lotte, as well as the Industrial Bank of Korea. Its main product, H-Medi, is a soft exosuit for gait rehabilitation certified as a Class 2 combination medical device by Korea's Ministry of Food and Drug Safety, and has been used at hospitals including Sinchon Severance since its commercial launch in September 2025. The money will go to overseas approvals and distribution for H-Medi and to developing and mass-producing H-Care, an everyday walking-assist robot.